Skip to main content

Table 3 Other specific requirements and conditions for contact precaution (CP)

From: Variability in contact precautions to control the nosocomial spread of multi-drug resistant organisms in the endemic setting: a multinational cross-sectional survey

MDRO Origin of responses Total responses Additional pre-emptive CP based on patient’s historya CP only required if specific risk factors presentb Additional pre-emptive CP but only if specific risk factors None applicable p-valuec
MRSA EU 126 117 (92.9) 1 (0.8) 1 (0.8) 7 (5.6) 0.038
Non EU 38 30 (78.9) 1 (2.6) 2 (5.3) 5 (13.2)
GRE EU 94 81 (86.2) 3 (3.2) 1 (1.1) 9 (9.6) 0.265
Non EU 30 24 (80.00) 2 (6.7) 2 (6.7) 2 (6.7)
ESBL E. coli EU 91 74 (81.3) 8 (8.8) 4 (4.7) 5 (4.7) 0.812
Non EU 26 22 (84.6) 1 (3.8) 2 (7.7) 1 (3.8)
ESBL non-E. coli EU 101 86 (85.1) 5 (5.0) 3 (3.0) 7 (6.9) 0.131
Non EU 23 18 (78.3) 3 (13.0) 2 (8.7) 0 (0.0)
Carbapenem resistant E. coli EU 120 103 (85.8) 4 (3.3) 4 (3.3) 9 (7.5) 0.465
Non EU 36 33 (91.7) 0 (0.0) 2 (5.6) 1 (2.8)
Carbapenem resistant Enterobacteriaceae (non-E. coli) EU 126 111 (88.1) 2 (1.6) 4 (3.2) 9 (7.1) 0.560
Non EU 37 33 (89.2) 1 (2.7) 2 (5.4) 1 (2.7)
MDR P. aeruginosa EU 112 96 (85.7) 3 (2.7) 4 (3.6) 9 (8.0) 0.178
Non EU 35 31 (88.6) 1 (2.9) 3 (8.6) 0 (0.0)
MDR A. baumannii EU 120 107 (89.2) 1 (0.8) 5 (4.2) 7 (5.8) 0.758
Non EU 33 31 (91.2) 0 (0.0) 2 (5.9) 1 (2.9)
  1. aFormerly positive for respective MDRO or presumptive infection/colonization with respective MDRO
  2. bCP only when certain risk factors present e.g. incontinence, diarrhoea, draining wounds
  3. cA two-sided p-value of < 0.05 was considered statistically significant